LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
BT-20 Dasatinib
3.33
uM
LJP6
 72
hr
 1097 985 3769 0.2615 -0.0418
BT-20 Dovitinib
3.33
uM
LJP5
 72
hr
 1097 1500 3769 0.3981 0.1510
BT-20 Enzastaurin
3.33
uM
LJP5
 72
hr
 1097 4264 3769 1.1313 1.1852
BT-20 Erlotinib
3.33
uM
LJP5
 72
hr
 1097 3231 3769 0.8573 0.7987
BT-20 Foretinib
3.33
uM
LJP5
 72
hr
 1097 1303 3769 0.3458 0.0772
BT-20 R406
3.33
uM
LJP6
 72
hr
 1097 3171 3769 0.8413 0.7761
BT-20 Pictilisib
3.33
uM
LJP6
 72
hr
 1097 1086 3769 0.2883 -0.0040
BT-20 Gefitinib
3.33
uM
LJP6
 72
hr
 1097 3134 3769 0.8314 0.7622
BT-20 Geldanamycin
3.33
uM
LJP5
 72
hr
 1097 936 3769 0.2483 -0.0603
BT-20 Geldanamycin
3.33
uM
LJP6
 72
hr
 1097 891 3769 0.2365 -0.0771
BT-20 GSK1059615
3.33
uM
LJP5
 72
hr
 1097 474 3769 0.1258 -0.2331
BT-20 GSK1059615
3.33
uM
LJP6
 72
hr
 1097 514 3769 0.1364 -0.2181
BT-20 GSK1904529A
3.33
uM
LJP6
 72
hr
 1097 3458 3769 0.9174 0.8835
BT-20 Omipalisib
3.33
uM
LJP6
 72
hr
 1097 491 3769 0.1304 -0.2266
BT-20 GSK 690693
3.33
uM
LJP5
 72
hr
 1097 2005 3769 0.5321 0.3399
BT-20 GW843682X
3.33
uM
LJP6
 72
hr
 1097 992 3769 0.2632 -0.0394
BT-20 HG-5-113-01
3.33
uM
LJP5
 72
hr
 1097 1818 3769 0.4823 0.2697
BT-20 HG-5-88-01
3.33
uM
LJP6
 72
hr
 1097 3320 3769 0.8808 0.8319
BT-20 Imatinib
3.33
uM
LJP6
 72
hr
 1097 3500 3769 0.9286 0.8993
BT-20 JNK-9L
3.33
uM
LJP6
 72
hr
 1097 887 3769 0.2355 -0.0784
BT-20 JW-7-24-1
3.33
uM
LJP6
 72
hr
 1097 1812 3769 0.4808 0.2676
BT-20 Lapatinib
3.33
uM
LJP6
 72
hr
 1097 3394 3769 0.9005 0.8596
BT-20 LDN-193189
3.33
uM
LJP5
 72
hr
 1097 357 3769 0.0947 -0.2770
BT-20 Linifanib
3.33
uM
LJP6
 72
hr
 1097 3739 3769 0.9920 0.9887
BT-20 Linsitinib
3.33
uM
LJP5
 72
hr
 1097 3521 3769 0.9342 0.9072